These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


297 related items for PubMed ID: 20598117

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nfkb 1 is dispensable for Myc-induced lymphomagenesis.
    Keller U, Nilsson JA, Maclean KH, Old JB, Cleveland JL.
    Oncogene; 2005 Sep 15; 24(41):6231-40. PubMed ID: 15940251
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.
    Truffinet V, Pinaud E, Cogné N, Petit B, Guglielmi L, Cogné M, Denizot Y.
    J Immunol; 2007 Nov 01; 179(9):6033-42. PubMed ID: 17947677
    [Abstract] [Full Text] [Related]

  • 7. The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.
    Cardone M, Kandilci A, Carella C, Nilsson JA, Brennan JA, Sirma S, Ozbek U, Boyd K, Cleveland JL, Grosveld GC.
    Mol Cell Biol; 2005 Mar 01; 25(6):2395-405. PubMed ID: 15743832
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Id2 is dispensable for myc-induced lymphomagenesis.
    Nilsson JA, Nilsson LM, Keller U, Yokota Y, Boyd K, Cleveland JL.
    Cancer Res; 2004 Oct 15; 64(20):7296-301. PubMed ID: 15492249
    [Abstract] [Full Text] [Related]

  • 12. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
    Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW.
    Nature; 2005 Aug 11; 436(7052):807-11. PubMed ID: 16094360
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, Nilsson LM, Neale G, Kramer DL, Porter CW, Cleveland JL.
    Cancer Cell; 2005 May 11; 7(5):433-44. PubMed ID: 15894264
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.